| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 83881-51-0 | 西替利嗪; 2-[2-[4-[(4-氯苯基)苯甲基]-1-哌嗪基]乙氧基]乙酸 | Cetirizine; 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid |  | C21H25ClN2O3 | 詳情 | 供應商 |
| 83881-52-1 | 鹽酸西替利嗪; (+/-)-2-[2-[4-[(4-氯苯基)苯甲基]-1-哌嗪基]乙氧基]乙酸二鹽酸鹽 | Cetirizine hydrochloride; 2-(2-{4-[(4-Chlorophenyl)(phenyl)-methyl]piperazino}ethoxy)acetic acid dihydrochloride |  | C21H25ClN2O3.2(HCl) | 詳情 | 供應商 |
| 130018-77-8 | 左西替利嗪; 2-[2-[4-[(4-氯苯基)-苯基甲基]哌嗪-1-基]乙氧基]乙酸 | Levocetirizine; Alerlisin; 2-[2-[4-[(4-Chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid |  | C21H25ClN2O3 | 詳情 | 供應商 |
| 125602-71-3 | 1-Piperidinebutanoicacid, 4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]-; Bepotastine |  | C21H25ClN2O3 | 詳情 | 供應商 | |
| 190786-43-7 | 1-Piperidinebutanoicacid, 4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]-; Bepotastine |  | C21H25ClN2O3 | 詳情 | 供應商 | |
| 190730-41-7 | 1-Piperidinebutanoicacid, 4-[(R)-(4-chlorophenyl)-2-pyridinylmethoxy]-; 1-Piperidinebutanoicacid, 4-[(4-chlorophenyl)-2-pyridinylmethoxy]-, (R)- |  | C21H25ClN2O3 | 詳情 | 供應商 | |
| 84176-73-8 | 4-Piperidinecarboxamide,4-(4-chlorophenyl)-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-; Isonipecotamide,4-(p-chlorophenyl)-N,N-dimethyl-1-(p-tolylsulfonyl)- (7CI) |  | C21H25ClN2O3S | 詳情 | 供應商 | |
| 4373-34-6 | Ajmalicine HCl |  | C21H25ClN2O3 | 詳情 | 供應商 | |
| 130018-76-7 | (S)-Cetirizine; (S)-[2-[4-[(4-Chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic Acid; Dextrocetirizin; Dextrocetirizine |  | C21H25ClN2O3 | 詳情 | 供應商 |